These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9676989)

  • 1. Molecular mechanisms of diabetic angiopathy--clues for innovative therapeutic interventions.
    Bierhaus A; Ziegler R; Nawroth PP
    Horm Res; 1998; 50 Suppl 1():1-5. PubMed ID: 9676989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of RAGE for attenuating progression of diabetic vascular complications.
    Win MT; Yamamoto Y; Munesue S; Saito H; Han D; Motoyoshi S; Kamal T; Ohara T; Watanabe T; Yamamoto H
    Exp Diabetes Res; 2012; 2012():894605. PubMed ID: 22110482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.
    Takeuchi M; Takino J; Yamagishi S
    Curr Drug Targets; 2010 Nov; 11(11):1468-82. PubMed ID: 20583971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
    Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T
    Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of diabetic vascular injury by controlling of AGE-RAGE system.
    Myint KM; Yamamoto Y; Sakurai S; Harashima A; Watanabe T; Li H; Takeuchi A; Yoshimura K; Yonekura H; Yamamoto H
    Curr Drug Targets; 2005 Jun; 6(4):447-52. PubMed ID: 16026264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].
    Nawroth PP; Bierhaus A; Vogel GE; Hofmann MA; Zumbach M; Wahl P; Ziegler R
    Med Klin (Munich); 1999 Jan; 94(1):29-38. PubMed ID: 10081287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
    Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
    Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
    Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.
    Bierhaus A; Ritz E; Nawroth PP
    Nephrol Dial Transplant; 1996; 11 Suppl 5():87-90. PubMed ID: 9044315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors.
    Vlassara H; Bucala R
    Diabetes; 1996 Jul; 45 Suppl 3():S65-6. PubMed ID: 8674896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease.
    Thomas MC; Baynes JW; Thorpe SR; Cooper ME
    Curr Drug Targets; 2005 Jun; 6(4):453-74. PubMed ID: 16026265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE: a novel target for drug intervention in diabetic vascular disease.
    Hudson BI; Schmidt AM
    Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possible participation of advanced glycation endproducts and their receptor system in the development of diabetic vascular complications].
    Yamamoto Y; Sakurai S; Watanabe T; Yonekura H; Yamamoto H
    Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):49-55. PubMed ID: 12617038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
    Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
    Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.
    Yamagishi S; Nakamura N; Suematsu M; Kaseda K; Matsui T
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S32-40. PubMed ID: 26605646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Participation of toxic AGEs (TAGE) in a variety of diseases].
    Takeuchi M
    Nihon Yakurigaku Zasshi; 2012 May; 139(5):193-7. PubMed ID: 22687870
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure.
    Aronson D
    Med Hypotheses; 2002 Sep; 59(3):297-301. PubMed ID: 12208156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications.
    Yamagishi S; Nakamura K; Matsui T; Ueda S; Fukami K; Okuda S
    Expert Opin Investig Drugs; 2008 Jul; 17(7):983-96. PubMed ID: 18549336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy.
    Yoon YW; Kang TS; Lee BK; Chang W; Hwang KC; Rhee JH; Min PK; Hong BK; Rim SJ; Kwon HM
    Exp Mol Med; 2008 Aug; 40(4):398-406. PubMed ID: 18779652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.